Is it appropriate to conduct a disproportionality analysis using a spontaneous reporting database to investigate whether drug-related adverse events are dose-dependent?

Ngā tūemi rite

• Disproportionality analysis of taste disorders using the FDA adverse event reporting system and Japanese adverse drug event report databases
  mā: Yoji Kyotani, me ētahi atu.
  I whakaputaina: (2025-11-01)
• A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases
  mā: Qian Liu, me ētahi atu.
  I whakaputaina: (2024-11-01)
• Analysis of Corticosteroid-Induced Glaucoma Using the Japanese Adverse Drug Event Reporting Database
  mā: Ayano Kawabe, me ētahi atu.
  I whakaputaina: (2023-06-01)
• Association between Polypharmacy and Adverse Events in Patients with Alzheimer’s Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER)
  mā: Nobuhiro Otani, me ētahi atu.
  I whakaputaina: (2024-10-01)
• Fact-Finding Survey and Exploration of Preventive Drugs for Antineoplastic Drug-Induced Oral Mucositis Using the Japanese Adverse Drug Event Report Database
  mā: Hajime Matsuo, me ētahi atu.
  I whakaputaina: (2024-06-01)